Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1,066,850
-
Shares change
-
-71,653
-
Total reported value, excl. options
-
$2,282,000
-
Value change
-
-$148,086
-
Number of buys
-
4
-
Number of sells
-
-6
-
Price
-
$2.14
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q3 2017
16 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q3 2017.
ProPhase Labs, Inc. - COM (PRPH) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,066,850 shares
.
Largest 10 shareholders include Vantage Investment Partners, LLC (433,335 shares), Bank of New York Mellon Corp (184,984 shares), RENAISSANCE TECHNOLOGIES LLC (155,662 shares), DIMENSIONAL FUND ADVISORS LP (146,457 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (47,401 shares), PNC FINANCIAL SERVICES GROUP, INC. (25,402 shares), UBS Group AG (22,095 shares), NORTHERN TRUST CORP (15,836 shares), DEUTSCHE BANK AG\ (14,462 shares), and Commonwealth Equity Services, Inc (11,000 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.